HAVN Life Competitors

We are Compass, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. We believe people living with mental health conditions deserve the possibility of a better future. Our initial focus is advancing COMP360, a proprietary, investigational synthetic psilocybin treatment being evaluated for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability, with infrequent dosing. We’re driven by our purpose of unlocking pathways to be—opening futures filled with possibility. Together, we’re on an ambitious journey toward enabling people living with mental health conditions to find clarity through self-discovery. Every journey needs a Compass.

Zylo is the enterprise standard for software and AI spend optimization, helping organizations bring financial truth to their SaaS portfolio. Its platform empowers organizations to manage SaaS at scale by providing the visibility, prescriptive insights, and expertise necessary to optimize their software investments. Powered by the industry's largest dataset of 40 million SaaS licenses and over $75 billion in SaaS spend, Zylo unlocks significant cost savings, mitigates business risk, and maximizes software value. Zylo is trusted by innovative companies such as AbbVie, Adobe, Atlassian, Intuit, Salesforce, and Yahoo to confidently manage their SaaS portfolios. Zylo has raised more than $72.5M to date and is backed by leading SaaS investors, including Bessemer Venture Partners, Menlo Ventures, Baird Capital's Venture Team, Spring Lake Equity Partners, High Alpha, GGV, Slack Fund, Salesforce Ventures, MassMutual Ventures, and Coupa Ventures. For more information, visit Zylo.com.

MindMed is now Definium Therapeutics, a rebrand that reflects our commitment to forging a new era of psychiatry by applying precision to psychedelic medicine. Follow our new page at the link below!